Target Audience: Emergency healthcare professionals both urban and rural, residents, medical students and all other interprofessional healthcare providers practicing emergency medicine.
Session Specific Objectives
By the end of this session, participants will be able to:
- Compare the effectiveness of Diltiazem and Metoprolol for rate control in patients with Atrial Fibrillation with rapid ventricular rate.
- Compare the safety and efficacy of different electrode placements for electrically cardioverting atrial fibrillation.
- Article 1: Dr. Andrew Tolmie (Resident) with Dr. Matthew Parsons (Faculty)
- Article 2: Dr. Kedra Peterson (Resident) with Dr. Cobus Van Der Merwe (Faculty).
- Anterior–Lateral Versus Anterior–Posterior Electrode Position for Cardioverting Atrial Fibrillation (Article Link) – Smaller randomized studies have reported conflicting results regarding the optimal electrode position for cardioverting atrial fibrillation. However, anterior–posterior electrode positioning is widely used as a standard and believed to be superior to anterior–lateral electrode positioning. Therefore, we aimed to compare anterior–lateral and anterior–posterior electrode positioning for cardioverting atrial fibrillation in a multicenter randomized trial.
- Intravenous diltiazem versus metoprolol for atrial fibrillation with rapid ventricular rate: A meta-analysis (Article Link) – Both commonly used to treat atrial fibrillation (AF) with rapid ventricular rate (RVR) in the emergency department (ED), but the advantages and disadvantages of these drugs cannot be verified. This meta-analysis aimed to assess the efficacy and safety of intravenous diltiazem versus metoprolol for AF with RVR.
June 23, 2022 | 6:00 to 7:00PM SK
View the recording from this session HERE